{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:45:03Z","timestamp":1794271503821,"version":"4.9.0"},"reference-count":54,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>Although significant progress has been made in prevention and treatment of HIV in the United States, nationally and globally, infants and children younger than 13\u00a0years have less access to optimal antiretroviral therapy compared with youth (13\u201324\u00a0years) and adults, which can negatively affect health outcomes for those with HIV. Despite youth having nearly as many antiretroviral options for HIV management as adults, optimal HIV management in youth is challenged by psychosocial and structural barriers that result in poor access to HIV prevention and care. Significant barriers remain in providing equitable access to optimal HIV treatment and prevention services in the pediatric population.<\/jats:p>","DOI":"10.1542\/peds.2025-072718","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:02:55Z","timestamp":1753056175000},"source":"Crossref","is-referenced-by-count":2,"title":["Increasing Access to Antiretroviral Therapy for the Prevention and Treatment of HIV in Infants, Children, and Youth in the United States: Policy Statement"],"prefix":"10.1542","volume":"156","author":[{"given":"Rosemary","family":"Olivero","sequence":"first","affiliation":[{"name":"1Section of Pediatric Infectious Diseases, Corewell Health Helen DeVos Children\u2019s Hospital, Grand Rapids, Michigan"},{"name":"2Department of Pediatrics and Human Development, Michigan State College of Human Medicine, Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gillespie","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Division of Immunology, Allergy and Retrovirology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee on Pediatric and Adolescent HIV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natella Yurievna","family":"Rakhmanina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Abuogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Neilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Olivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rosebush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Siberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"1","key":"2025091113071071900_r1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era","volume":"53","author":"Brady","year":"2010","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"10","key":"2025091113071071900_r2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/cid\/cir641","article-title":"Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986\u20132004)","volume":"53","author":"Kapogiannis","year":"2011","journal-title":"Clin Infect Dis."},{"issue":"12","key":"2025091113071071900_r3","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/cid\/civ687","article-title":"Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy","volume":"61","author":"Mirani","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2025091113071071900_r4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/INF.0000000000003154","article-title":"Opportunistic illnesses in children with HIV infection in the United States, 1997\u20132016","volume":"40","author":"Nesheim","year":"2021","journal-title":"Pediatr Infect Dis J."},{"issue":"12","key":"2025091113071071900_r5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.1995.03530120044039","article-title":"Prevalence and incidence of vertically acquired HIV infection in the United States","volume":"274","author":"Davis","year":"1995","journal-title":"JAMA."},{"issue":"5","key":"2025091113071071900_r6","doi-asserted-by":"crossref","first-page":"e2020029058","DOI":"10.1542\/peds.2020-029058","article-title":"Evaluation and management of the infant exposed to HIV in the United States","volume":"146","author":"Chadwick","year":"2020","journal-title":"Pediatrics."},{"issue":"4","key":"2025091113071071900_r7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1542\/peds.2012-0194","article-title":"A framework for elimination of perinatal transmission of HIV in the United States","volume":"130","author":"Nesheim","year":"2012","journal-title":"Pediatrics."},{"key":"2025091113071071900_r8","volume-title":"Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection","author":"Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV","year":"2025"},{"key":"2025091113071071900_r9","article-title":"Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States","author":"National Institutes of Health","year":"2025"},{"issue":"1","key":"2025091113071071900_r10","doi-asserted-by":"crossref","first-page":"e2021055207","DOI":"10.1542\/peds.2021-055207","article-title":"Adolescents and young adults: the pediatrician\u2019s role in HIV testing and pre- and postexposure HIV prophylaxis","volume":"149","author":"Hsu","year":"2022","journal-title":"Pediatrics."},{"key":"2025091113071071900_r11","article-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States -- 2021 update : a clinical practice guideline","author":"US Public Health Service, Centers for Disease Control and Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV\/AIDS Prevention, Preexposure Prophylaxis Work Group","year":"2021"},{"issue":"10","key":"2025091113071071900_r12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1542\/pir.2018-0040","article-title":"Confidentiality and consent in the care of the adolescent patient","volume":"40","author":"Maslyanskaya","year":"2019","journal-title":"Pediatr Rev."},{"issue":"6","key":"2025091113071071900_r13","doi-asserted-by":"crossref","first-page":"e2021053458","DOI":"10.1542\/peds.2021-053458","article-title":"State-by-state variability in adolescent privacy laws","volume":"149","author":"Sharko","year":"2022","journal-title":"Pediatrics."},{"issue":"RR-14","key":"2025091113071071900_r14","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep."},{"issue":"4","key":"2025091113071071900_r15","doi-asserted-by":"crossref","first-page":"e20170254","DOI":"10.1542\/peds.2017-0254","article-title":"2017 recommendations for preventive pediatric health care","volume":"139","author":"Richerson","year":"2017","journal-title":"Pediatrics."},{"issue":"4","key":"2025091113071071900_r16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect Dis."},{"issue":"9","key":"2025091113071071900_r17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med."},{"issue":"9","key":"2025091113071071900_r18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med."},{"issue":"3","key":"2025091113071071900_r19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMoa0910370","article-title":"Early versus standard antiretroviral therapy for HIV-infected adults in Haiti","volume":"363","author":"Severe","year":"2010","journal-title":"N Engl J Med."},{"issue":"11","key":"2025091113071071900_r20","doi-asserted-by":"crossref","first-page":"e27463","DOI":"10.1371\/journal.pone.0027463","article-title":"Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption","volume":"6","author":"Wyl","year":"2011","journal-title":"PLoS One."},{"issue":"3","key":"2025091113071071900_r21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAD.0000000000000528","article-title":"Early viral suppression improves neurocognitive outcomes in HIV-infected children","volume":"29","author":"Crowell","year":"2015","journal-title":"AIDS."},{"issue":"5","key":"2025091113071071900_r22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/rmv.1793","article-title":"Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy","volume":"24","author":"Crowell","year":"2014","journal-title":"Rev Med Virol."},{"issue":"suppl 1","key":"2025091113071071900_r23","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/jpids\/piw051","article-title":"Deformed subcortical structures are related to past HIV disease severity in youth with perinatally acquired HIV infection","volume":"5","author":"Lewis-de Los Angeles","year":"2016","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"11","key":"2025091113071071900_r24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/cid\/ciy362","article-title":"Longitudinal trajectories of brain volume and cortical thickness in treated and untreated primary human immunodeficiency virus infection","volume":"67","author":"Sanford","year":"2018","journal-title":"Clin Infect Dis."},{"issue":"5","key":"2025091113071071900_r25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/QAD.0b013e328326ca37","article-title":"Effect of early antiretroviral therapy on the risk of AIDS\/death in HIV-infected infants","volume":"23","author":"Goetghebuer","year":"2009","journal-title":"AIDS."},{"key":"2025091113071071900_r26","article-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV","author":"Department of Health and Human Services"},{"issue":"2","key":"2025091113071071900_r27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.aids.0000200535.02232.1b","article-title":"Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta","volume":"20","author":"Brennan-Benson","year":"2006","journal-title":"AIDS."},{"issue":"5","key":"2025091113071071900_r28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/sti.79.5.419","article-title":"Selective transmission of multidrug resistant HIV to a newborn related to poor maternal adherence","volume":"79","author":"Desai","year":"2003","journal-title":"Sex Transm Infect."},{"issue":"10","key":"2025091113071071900_r29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.aids.0000233587.94961.4f","article-title":"Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir","volume":"20","author":"Wensing","year":"2006","journal-title":"AIDS."},{"issue":"11","key":"2025091113071071900_r30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/cid\/ciab744","article-title":"Maternal human immunodeficiency virus (HIV) drug resistance is associated with vertical transmission and is prevalent in infected infants","volume":"74","author":"Boyce","year":"2022","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2025091113071071900_r31","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/INF.0b013e31827f44ee","article-title":"Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants","volume":"32","author":"Fogel","year":"2013","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"2025091113071071900_r32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00126334-200402010-00015","article-title":"Breast-feeding and transmission of HIV-1","volume":"35","author":"John-Stewart","year":"2004","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"1","key":"2025091113071071900_r33","doi-asserted-by":"crossref","first-page":"e26052","DOI":"10.1002\/jia2.26052","article-title":"Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings","volume":"26","author":"Dugdale","year":"2023","journal-title":"J Int AIDS Soc."},{"key":"2025091113071071900_r34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejpb.2020.10.017","article-title":"Bitter-blockers as a taste masking strategy: a systematic review towards their utility in pharmaceuticals","volume":"158","author":"Andrews","year":"2021","journal-title":"Eur J Pharm Biopharm."},{"key":"2025091113071071900_r35","article-title":"Global Accelerator for Paediatric Formulations Network (GAP-f)","author":"World Health Organization"},{"issue":"11","key":"2025091113071071900_r36","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/cid\/cix194","article-title":"Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations","volume":"64","author":"Penazzato","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"9","key":"2025091113071071900_r37","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/S2352-3018(19)30193-6","article-title":"Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list","volume":"6","author":"Penazzato","year":"2019","journal-title":"Lancet HIV."},{"issue":"9","key":"2025091113071071900_r38","doi-asserted-by":"crossref","first-page":"e658","DOI":"10.1016\/S2352-3018(22)00101-1","article-title":"Advancing the prevention and treatment of HIV in children: priorities for research and development","volume":"9","author":"Penazzato","year":"2022","journal-title":"Lancet HIV."},{"key":"2025091113071071900_r39","article-title":"Paediatric HIV & TB: Rome Action Plan","author":"Rome Action Plan"},{"issue":"1","key":"2025091113071071900_r40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/pch\/13.1.19","article-title":"Adherence to treatment in adolescents","volume":"13","author":"Taddeo","year":"2008","journal-title":"Paediatr Child Health."},{"key":"2025091113071071900_r41","article-title":"National Clinician Consultation Center","author":"AIDS Education & Training Center Program"},{"issue":"1","key":"2025091113071071900_r42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0000000000000597","article-title":"Long-acting injectable cabotegravir for the prevention of HIV infection","volume":"15","author":"Clement","year":"2020","journal-title":"Curr Opin HIV AIDS."},{"key":"2025091113071071900_r43","article-title":"FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention","author":"US Food and Drug Administration","year":"2021"},{"issue":"1","key":"2025091113071071900_r44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/QAI.0000000000002308","article-title":"The HIV continuum of care for adolescents and young adults attending 13 urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative","volume":"84","author":"Kapogiannis","year":"2020","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"3","key":"2025091113071071900_r45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/apc.2013.0345","article-title":"The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities","volume":"28","author":"Zanoni","year":"2014","journal-title":"AIDS Patient Care STDs."},{"issue":"suppl 5","key":"2025091113071071900_r46","doi-asserted-by":"crossref","first-page":"e25576","DOI":"10.1002\/jia2.25576","article-title":"The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV","volume":"23","author":"Rojo","year":"2020","journal-title":"J Int AIDS Soc."},{"issue":"11","key":"2025091113071071900_r47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaac.2022.04.020","article-title":"Social determinants of health, structural racism, and the impact on child and adolescent mental health","volume":"61","author":"Cotton","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"2","key":"2025091113071071900_r48","doi-asserted-by":"crossref","first-page":"e20191765","DOI":"10.1542\/peds.2019-1765","article-title":"The impact of racism on child and adolescent health","volume":"144","author":"Trent","year":"2019","journal-title":"Pediatrics."},{"issue":"3","key":"2025091113071071900_r49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1542\/peds.2013-4061","article-title":"Psychosocial support for youth living with HIV","volume":"133","author":"Martinez","year":"2014","journal-title":"Pediatrics."},{"key":"2025091113071071900_r50","article-title":"Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have Been Displaced by Disasters (such as a Hurricane)","year":"2021"},{"issue":"5","key":"2025091113071071900_r51","doi-asserted-by":"crossref","first-page":"e2022059604","DOI":"10.1542\/peds.2022-059604","article-title":"Achieving elimination of perinatal HIV in the United States","volume":"151","author":"Lampe","year":"2023","journal-title":"Pediatrics."},{"issue":"2","key":"2025091113071071900_r52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/jwh.2020.8882","article-title":"Social and structural determinants of health inequities in maternal health","volume":"30","author":"Crear-Perry","year":"2021","journal-title":"J Womens Health (Larchmt)."},{"key":"2025091113071071900_r53","article-title":"HIV Surveillance Report","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2025091113071071900_r54","article-title":"HIV Surveillance Report: Diagnoses of HIV Infection in the United States and Dependent Areas, 2021","author":"Centers for Disease Control and Prevention","year":"2023"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-072718\/1837436\/pediatrics.2025072718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-072718\/1837436\/pediatrics.2025072718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:07:28Z","timestamp":1757610448000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/156\/2\/e2025072718\/202660\/Increasing-Access-to-Antiretroviral-Therapy-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,21]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-072718","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"e2025072718"}}